Foghorn Therapeutics Inc. (FHTX) stock
FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/300% above fair value
$2.05−0.04 (-1.91%)
Close on Nov 12, 2026Market cap $121.74MP/E 29.3Yield –
Foghorn Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Foghorn Therapeutics's operating margin for the twelve months ending Sep 30, 2026 was 2.1%. For fiscal 2025 it was -279.5%, against -454.3% the year before. The highest annual figure on record is -279.5% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -279.5% | +174.8 |
| FY2024 | Dec 31, 2024 | -454.3% | −138.4 |
| FY2023 | Dec 31, 2023 | -315.9% | +293.3 |
| FY2022 | Dec 31, 2022 | -609.2% | +7027.9 |
| FY2021 | Dec 31, 2021 | -7637.1% | +8300.3 |
| FY2020 | Dec 31, 2020 | -15937.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 67.8% | +294.7 |
| Q2 FY2026 | Jun 30, 2026 | -54.8% | +224.4 |
| Q1 FY2026 | Mar 31, 2026 | -660.3% | −275.4 |
| Q4 FY2025 | Dec 31, 2025 | -258.2% | +582.3 |
| Q3 FY2025 | Sep 30, 2025 | -226.9% | +78.6 |
| Q2 FY2025 | Jun 30, 2025 | -279.2% | +107.5 |
| Q1 FY2025 | Mar 31, 2025 | -385.0% | +173.3 |
| Q4 FY2024 | Dec 31, 2024 | -840.5% | −399.2 |
| Q3 FY2024 | Sep 30, 2024 | -305.5% | −207.8 |
| Q2 FY2024 | Jun 30, 2024 | -386.6% | +185.8 |
| Q1 FY2024 | Mar 31, 2024 | -558.3% | +69.3 |
| Q4 FY2023 | Dec 31, 2023 | -441.3% | +320.8 |
| Q3 FY2023 | Sep 30, 2023 | -97.7% | +328.2 |
| Q2 FY2023 | Jun 30, 2023 | -572.4% | +77.6 |
| Q1 FY2023 | Mar 31, 2023 | -627.6% | +81.7 |
| Q4 FY2022 | Dec 31, 2022 | -762.1% | +3176.5 |
| Q3 FY2022 | Sep 30, 2022 | -426.0% | +63625.2 |
| Q2 FY2022 | Jun 30, 2022 | -650.1% | +7687.2 |
| Q1 FY2022 | Mar 31, 2022 | -709.3% | +7378.1 |
| Q4 FY2021 | Dec 31, 2021 | -3938.6% | +4339.9 |
| Q3 FY2021 | Sep 30, 2021 | -64051.2% | −53722.2 |
| Q2 FY2021 | Jun 30, 2021 | -8337.3% | – |
| Q1 FY2021 | Mar 31, 2021 | -8087.4% | – |
| Q4 FY2020 | Dec 31, 2020 | -8278.5% | – |
| Q3 FY2020 | Sep 30, 2020 | -10329.1% | – |
See a number that looks wrong?